United Laboratories International Holdings Dividends and Buybacks
Dividend criteria checks 3/6
United Laboratories International Holdings is a dividend paying company with a current yield of 5.17% that is well covered by earnings.
Key information
5.2%
Dividend yield
0.004%
Buyback Yield
| Total Shareholder Yield | 5.2% |
| Future Dividend Yield | 2.9% |
| Dividend Growth | 21.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.615 |
| Payout ratio | 27% |
Recent dividend and buyback updates
Recent updates
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Jan 10
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Oct 23Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 3933 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 3933's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
| United Laboratories International Holdings Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (3933) | 5.2% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Pharmaceuticals) | 4.0% |
| Analyst forecast (3933) (up to 3 years) | 2.9% |
Notable Dividend: 3933's dividend (5.17%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.33%).
High Dividend: 3933's dividend (5.17%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.01%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (27.5%), 3933's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (70.9%), 3933's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 13:55 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The United Laboratories International Holdings Limited is covered by 30 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ying Shao | BofA Global Research |
| Yue-Kwong Lui | CGS International |
| Bo Yu | China International Capital Corporation Limited |